`

Acorda Therapeutics, Inc

Biotechnology Research

Specialities :
Developing and commercializing therapies that improve the lives of people with nervous system disorders
Including multiple sclerosis (ms)
Spinal cord injury (sci)
Stroke and epilepsy. also developing a therapeutic approach for chronic heart failure.
Last Updated: November 20, 2025
Revenue
$115.66M
funding-icon Total Funding
$151.60M
Size
51 - 200

Frequently Asked Questions About Acorda Therapeutics, Inc

What does Acorda therapeutics, inc do?+

Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: investing in research and development collaborating...

What are Acorda therapeutics, inc's specialties? +

Developing and commercializing therapies that improve the lives of people with nervous system disorders,including multiple sclerosis (ms),spinal cord injury (sci),stroke and epilepsy. also developing a therapeutic approach for chronic heart failure.

What is Acorda therapeutics, inc's industry? +

Acorda therapeutics, inc operates in the Biotechnology research industry.

What is Acorda therapeutics, inc's revenue? +

Acorda therapeutics, inc's revenue is $115.66m

What is Acorda therapeutics, inc's company size? +

Acorda therapeutics, inc has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.